Related Experiment Video
Updated: May 14, 2026
06:36
Murine Excisional Wound Healing Model and Histological Morphometric Wound Analysis
Published on: August 21, 2020
Exploiting PI3K/mTOR signaling to accelerate epithelial wound healing
R M Castilho1, C H Squarize, J S Gutkind
1Laboratory of Epithelial Biology, Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, MI 48109-1078, USA. rcastilh@umich.edu
Oral Diseases
|February 6, 2013
Summary
The PI3K/Akt/mTOR pathway significantly impacts skin repair. Understanding its role in epithelial cell migration and proliferation offers new strategies for accelerating wound healing, especially for critical-size injuries.
Area of Science:
- Dermatology and regenerative medicine
- Molecular biology and cell signaling
Background:
- Skin wound healing involves complex molecular circuitries.
- Adult skin epithelial stem cells are crucial for tissue homeostasis and repair.
- The PI3K/Akt/mTOR pathway is a key regulator of epithelial functions.
Purpose of the Study:
- To review recent findings on wound healing mechanisms.
- To focus on the upregulation of the PI3K/Akt/mTOR pathway in skin repair.
- To explore therapeutic strategies for accelerating wound healing.
Main Methods:
- Review of recent scientific literature.
- Analysis of animal models dissecting the PI3K/Akt/mTOR pathway.
- Focus on molecular mechanisms controlling mTOR activation.
Main Results:
- The PI3K/Akt/mTOR pathway is significantly upregulated during wound healing.
- mTOR activation is critical for epithelial cell migration and proliferation.
- This pathway provides insights into skin homeostasis and regeneration.
Conclusions:
- The PI3K/Akt/mTOR pathway is a vital target for enhancing skin wound healing.
- Understanding mTOR activation mechanisms can lead to novel pharmacological interventions.
- Accelerating the healing of critical-size wounds is a key therapeutic goal.
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:19Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...